Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth.

Two new classifications for myeloid neoplasms were introduced in 2022: the International Consensus Classification (ICC) and the 5th edition WHO Classification (WHO-HAEM5). Both classifications build ...

Challenges of liquid panel in genomic profiling of esophageal squamous cell carcinoma (ESCC): Insights from an analysis of over 1000 cases. This is an ASCO Meeting Abstract from the ASCO Breakthrough: ...

Neural networks trained with a camouflage detection step show enhanced accuracy and sensitivity in identifying brain tumors from MRI scans, mimicking expert radiologists. Study: Deep learning and ...